z-logo
open-access-imgOpen Access
Modification of drug-induced catatonia and tremors by quipazine in rats and mice.
Author(s) -
Kulkarni Sk,
Ardeshir Arzi,
Pushkar N. Kaul
Publication year - 1980
Publication title -
japanese journal of pharmacology/japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.30.129
Subject(s) - quipazine , pharmacology , serotonergic , serotonin agonist , medicine , histaminergic , agonist , drug , amantadine , serotonin , diphenhydramine , cyproheptadine , cholinergic , receptor , histamine
Administration of perphenazine, tremorine, nicotine and harmine induced Parkinson-like symptoms in rats and mice. The efficacy of quipazine, a serotonin agonist, in antagonizing these drug-induced Parkinsonian symptoms was assessed. Combinations of this drug with other antiparkinsonian agents such as scopolamine, diphenhydramine and amantadine were also studied in the manifestation of Parkinson-like symptoms in the animal models. The results indicate that quipazine, a central serotonergic agent, counteracted some of the drug-induced symptoms of pseudoparkinsonism in laboratory animals. Cholinergic, dopaminergic and histaminergic receptors play an important role in the manifestations of these symptoms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here